http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1685472-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a3e8d85290229ab0bd27b752335a2253 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-30 |
| filingDate | 1988-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1991-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccdcb74375c69294a809a081156b8873 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d22fb65a6d14592ee7799634f043ffbb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a2cc46bd49d1f200c15860bca1f2ff9 |
| publicationDate | 1991-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SU-1685472-A1 |
| titleOfInvention | Method for treatment of patients affected by viral hepatitis |
| abstract | The invention relates to the field of medicine and concerns infectious diseases. The purpose of the invention is to reduce the treatment time of patients with viral hepatitis by pyrogenal electrophoresis from the negative pole daily, and the dose of pyrogenal is selected individually, under the control of an adaptation activation reaction. In the treatment according to the proposed method, the patient stay in the inpatient hospital was at an average form of 30.5 ± 1.6 beds (versus 37.2 ± 1.7 for treatment according to the method of the prototype), and at a severe 40.3 ± 1.9 (against 48.4 ± 1.3 days). |
| priorityDate | 1988-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.